ARCHIVES

Jerome Yates Named VP For Research At ACS

This article is from The Cancer Letter archive.

Vol. 28 No. 06 | February 8, 2002

Download PDF Visit The Full Archive

Related Articles

Centers Core Support To Be Trimmed By Dropping Funds for Scientists Salaries, Shared Resources

September 23, 1977

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

Murray Copeland Display Dedicated

March 18, 1983

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

NCI To Implement Recommendations, Sondik Says

September 2, 1988

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988